Market Overview

UPDATE: Stifel Nicolaus Downgrades Markel Corporation to Hold Following Acquisition

Related MKL
Wall Street's M&A Chatter From July 26: Biomarin, Sigma Designs, Colgate-Palmolive, Markel-State National
Closing In On The $1,000 Psychological Barrier

Stifel Nicolaus reduced its rating on Markel Corporation (NYSE: MKL) from Buy to Hold and removed its $550 price target.

Stifel Nicolaus commented, "We are downgrading the shares of Markel to Hold from Buy following its announced acquisition of Alterra (ALTE: $28.18, Not Covered). We think Markel's own overwhelmingly positive long-term underwriting track record challenges the cited benefits of increased diversification, product depth, and leadership positions. We're concerned about integration-related distractions in general, and the prospect of less-favorable reserve development in particular, likely limiting near-term book value creation. Long term-focused investors can rely on Markel's proven ability to re-underwrite books of business over time, but the near-term outlook seems too uncertain to warrant a Buy rating."

Markel Corporation closed at $436.24 on Wednesday.

Latest Ratings for MKL

Nov 2016William BlairDowngradesOutperformMarket Perform
Aug 2016SunTrust Robinson HumphreyMaintainsNeutral
Apr 2016William BlairUpgradesMarket PerformOutperform

View More Analyst Ratings for MKL
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Downgrades Intraday Update Analyst Ratings


Related Articles (MKL)

View Comments and Join the Discussion!